CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Christian Waage Director | Grant or award · Stock Option (Right to Buy) | +35,900 | 35,900 | ||
| 2025-01-31 | Forbes William P EVP, Chief Development Officer | Grant or award · Employee Stock Option (Right to Buy) | +374,220 | 374,220 | ||
| 2025-01-31 | Forbes William P EVP, Chief Development Officer | Grant or award · Restricted Stock Units | +187,110 | 187,110 | ||
| 2025-01-31 | Duarte Ira EVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +374,220 | 374,220 | ||
| 2025-01-31 | Duarte Ira EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +187,110 | 187,110 | ||
| 2025-01-31 | Collard Craig A Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +1,113,240 | 1,113,240 | ||
| 2025-01-31 | Collard Craig A Chief Executive Officer | Grant or award · Restricted Stock Units | +556,620 | 556,620 | ||
| 2025-01-30 | Kaseta Michael Director | Grant or award | +17,950 | 55,829 | ||
| 2025-01-30 | Kaseta Michael Director | Grant or award · Stock Option (Right to Buy) | +35,900 | $1.73 | $62K | 35,900 |
| 2025-01-30 | Dissanaike Sharmila Director | Grant or award | +17,950 | 87,180 | ||
| 2025-01-30 | Dissanaike Sharmila Director | Grant or award · Stock Option (Right to Buy) | +35,900 | $1.73 | $62K | 35,900 |
| 2025-01-30 | Johnson Craig A Director | Grant or award | +17,950 | 83,770 | ||
| 2025-01-30 | Johnson Craig A Director | Grant or award · Stock Option (Right to Buy) | +35,900 | $1.73 | $62K | 35,900 |
| 2025-01-30 | Rodriguez Susan Director | Grant or award | +17,950 | 87,180 | ||
| 2025-01-30 | Rodriguez Susan Director | Grant or award · Stock Option (Right to Buy) | +35,900 | $1.73 | $62K | 35,900 |
| 2025-01-30 | Christian Waage Director | Grant or award | +17,950 | 84,130 | ||
| 2025-01-30 | Christian Waage Director | Grant or award · Stock Option (Right to Buy) | +35,900 | $1.73 | $62K | 35,900 |
| 2025-01-30 | Morgan Adam Director | Grant or award | +17,950 | 69,777 | ||
| 2025-01-30 | Morgan Adam Director | Grant or award · Stock Option (Right to Buy) | +35,900 | $1.73 | $62K | 35,900 |
| 2025-01-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +3,874 | 120,580 |
Page 10 of 28 · 557 trades